(SMMT) stock rises as its lung cancer drug ivonescimab with chemotherapy hit the main goal in a Phase 3 trial for lung cancer ...

The test could help direct prostate cancer patients to the best treatment option for them, researchers behind the findings ...

Replacing PEG with PCB in lipid nanoparticles led to potent mRNA vaccines that avoided unwanted immune responses.

Kane Biotech announced on April 28, 2025 that the CEO was no longer with the Company. The former CEO recently filed and served a legal action for $445,000 related to his employment agreement with Kane ...